Related references
Note: Only part of the references are listed.Human herpesvirus-6 and-7 after lung and heart-lung transplantation
Juho T. Lehto et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2007)
Modulation of eotaxin-3 (CCL26) in alveolar type II epithelial cells
Barack O. Abonyo et al.
CYTOKINE (2006)
Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival
Ilkka Helantera et al.
TRANSPLANT INTERNATIONAL (2006)
Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation
Elfriede Ruttmann et al.
TRANSPLANTATION (2006)
Human herpesvirus 6 in bronchalveolar lavage fluid after lung transplantation:: A risk factor for bronchiolitis obliterans syndrome?
C Neurohr et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
CXCR2/CXCR2 ligand biology ischemia-reperfusion injury
JA Belperio et al.
JOURNAL OF IMMUNOLOGY (2005)
The effect of primary graft dysfunction on survival after lung transplantation
JD Christie et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome
JA Belperio et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection
JJ Yun et al.
CIRCULATION (2004)
Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients
F Pereyra et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2004)
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
S Sagedal et al.
KIDNEY INTERNATIONAL (2004)
Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome
M Tamm et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
The role of innate immunity in acute allograft rejection after lung transplantation
SM Palmer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures
A Caruso et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Cytomegalovirus viremia associated with death or retransplantation in pediatric lung-transplant recipients
LA Danziger-Isakov et al.
TRANSPLANTATION (2003)
Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1α (CCL3) after allogeneic BMT in mice
A Panoskaltsis-Mortari et al.
BLOOD (2003)
Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease
J Kao et al.
CIRCULATION (2003)
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
S Sagedal et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection
K McLaughlin et al.
TRANSPLANTATION (2002)
Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration
M Reynaud-Gaubert et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2002)
Definitions of cytomegalovirus infection and disease in transplant recipients
P Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2002)
Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria
M Estenne et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2002)
Beneficial effects of targeting CCR5 in allograft recipients
W Gao et al.
TRANSPLANTATION (2001)
Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome
JA Belperio et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
CC chemokine receptor 5 and renal-transplant survival
M Fischereder et al.
LANCET (2001)
The chemokine macrophage-inflammatory protein-1α and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection
JB Domachowske et al.
JOURNAL OF IMMUNOLOGY (2000)
The role of the CC chemokine, RANTES, in acute lung allograft rejection
JA Belperio et al.
JOURNAL OF IMMUNOLOGY (2000)
A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense
TP Salazar-Mather et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
